| 15-ADON | 15-acetyldeoxynivalenol |
| 3-ADON | 3-acetyldeoxynivalenol |
| Aβ | amyloid beta |
| ACN | acetonitrile |
| AD | Alzheimer´s disease |
| AFB1 | aflatoxin B1 |
| AFB2 | aflatoxin B2 |
| AFG1 | aflatoxin G1 |
| AFG2 | aflatoxin G2 |
| AFM1 | aflatoxin M1 |
| CIRS | chronic inflammatory response syndrome |
| CNT | control |
| DAS | diacetoxyscirpenol |
| DOM-1 | deepoxy-deoxynivalenol |
| DON | deoxynivalenol |
| FUS-X | fusarenon-X |
| GDS | Global Deterioration Scale |
| HBM | human biomonitoring |
| HY | Hoehn and Yahr |
| LC | liquid chromatography |
| LC-MS/MS | liquid chromatography coupled to mass spectrometry in tandem |
| LOD | limit of detection |
| LOQ | limit of quantification |
| NEO | neosolaniol |
| NIV | nivalenol |
| OTA | ochratoxin A |
| OTA-d5 | ochratoxin A-(phenyl-d5) |
| OTB | ochratoxin B |
| PD | Parkinson´s disease |
| q | transition of qualification |
| Q | transition of quantification |
| QqQ | triple quadrupole |
| RE | relative error of the mean |
| SD | standard deviation |
| STER | sterigmatocystin |
| ZEA | zearalenone |